It has come to our attention that there was an error in Figure 7A in the published version of above-mentioned article (1). Upon review, we have identified that Figure 7A (DG male control group) closely resembles data presented in Figure 6A (DG control group) of another publication (2).
The authors acknowledge this error and clarify that this does not affect the scientific conclusions of the study. The original article has been updated accordingly.
Corrected Figure 7A and caption:
Figure 7.
Production of dark neurons in the hippocampal CA1, CA2, and dentate gyrus in adult rats after repeated sevoflurane exposure in pre-adolescence. A, Light-microscopic appearance of toluidine blue-stained dark neurons in 10-μm hippocampus sections (CA1, CA2, and DG areas); B, Dark neuron numbers in CA1 and CA2 regions of the sevoflurane groups were significantly higher than in the control groups (P < 0.001 male sevoflurane vs. male control in CA1 and CA2 (#P < 0.05 female sevoflurane vs. female control in CA1 and CA2; P < 0.05 male sevoflurane vs. male control in DG region). All graphs are presented as mean ± SEM.
We sincerely apologize for this oversight and any inconvenience it may have caused.
Sincerely,
Dr. Fhanik Babaei
The Corresponding Author
![Erratum for “Evaluation of the Neuroprotective Effect of Chalcone on P53 and Caspase III Expression and D2-Like Dopaminergic Receptor Up-Regulation in vitro Parkinson's Model [J Cell Mol Anesth. 2022; 8 (1): e151424]”](https://brieflands.com/journals/jcma/articles/165378/figures/thumbnail.webp)
